Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Total Liabilities (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Total Liabilities for 16 consecutive years, with $66.3 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 4.79% to $66.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $66.3 million through Dec 2025, up 4.79% year-over-year, with the annual reading at $66.3 million for FY2025, 4.79% up from the prior year.
  • Total Liabilities for Q4 2025 was $66.3 million at Harvard Bioscience, up from $63.9 million in the prior quarter.
  • The five-year high for Total Liabilities was $81.7 million in Q1 2022, with the low at $61.7 million in Q2 2024.
  • Average Total Liabilities over 5 years is $69.8 million, with a median of $66.9 million recorded in 2023.
  • The sharpest move saw Total Liabilities increased 10.16% in 2022, then decreased 13.19% in 2023.
  • Over 5 years, Total Liabilities stood at $78.9 million in 2021, then fell by 7.35% to $73.1 million in 2022, then decreased by 12.1% to $64.3 million in 2023, then decreased by 1.54% to $63.3 million in 2024, then rose by 4.79% to $66.3 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $66.3 million, $63.9 million, and $64.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.